These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 20621566)
21. Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Villar LM; Masjuan J; Sádaba MC; González-Porqué P; Plaza J; Bootello A; Alvarez-Cermeño JC Arch Neurol; 2005 Apr; 62(4):574-7. PubMed ID: 15824255 [TBL] [Abstract][Full Text] [Related]
22. A new risk variant for multiple sclerosis at the immunoglobulin heavy chain locus associates with intrathecal IgG, IgM index and oligoclonal bands. Delgado-García M; Matesanz F; Alcina A; Fedetz M; García-Sánchez MI; Ruiz-Peña JL; Fernández Ó; Pinto Medel MJ; Leyva L; Arnal C; Delgado C; López Guerrero JA; González-Pérez A; Sáez ME; Villar LM; Álvarez-Cermeño JC; Picón C; Arroyo R; Varadé J; Urcelay E; Izquierdo G; Lucas M Mult Scler; 2015 Aug; 21(9):1104-11. PubMed ID: 25392328 [TBL] [Abstract][Full Text] [Related]
23. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis]. Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427 [TBL] [Abstract][Full Text] [Related]
24. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075 [TBL] [Abstract][Full Text] [Related]
25. [Intrathecal oligoclonal and polyspecific immune response in multiple sclerosis]. Robinson Agramonte MA; Reiber H; Dorta Contreras AJ; Hernández Díaz E Rev Neurol; 2001 Nov 1-15; 33(9):809-11. PubMed ID: 11784982 [TBL] [Abstract][Full Text] [Related]
26. Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF. Warnke C; Stettner M; Lehmensiek V; Dehmel T; Mausberg AK; von Geldern G; Gold R; Kümpfel T; Hohlfeld R; Mäurer M; Stangel M; Straeten V; Limmroth V; Weber T; Kleinschnitz C; Wattjes MP; Svenningsson A; Olsson T; Hartung HP; Hermsen D; Tumani H; Adams O; Kieseier BC Mult Scler; 2015 Jul; 21(8):1036-44. PubMed ID: 25392339 [TBL] [Abstract][Full Text] [Related]
27. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset. Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856 [TBL] [Abstract][Full Text] [Related]
28. [Progress of research in the diagnosis of multiple sclerosis by study of the cerebrospinal fluid]. Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V Psychiatr Neurol Med Psychol (Leipz); 1987 Nov; 39(11):651-61. PubMed ID: 2450384 [TBL] [Abstract][Full Text] [Related]
29. Intrathecal human herpesvirus 6 antibodies in multiple sclerosis and other demyelinating diseases presenting as oligoclonal bands in cerebrospinal fluid. Virtanen JO; Pietiläinen-Nicklén J; Uotila L; Färkkilä M; Vaheri A; Koskiniemi M J Neuroimmunol; 2011 Aug; 237(1-2):93-7. PubMed ID: 21767883 [TBL] [Abstract][Full Text] [Related]
30. Studies on anti-myelin antibodies in patients with multiple sclerosis. Nobile-Orazio E; Spagnol G; Daverio R; Riboni L; Macchi R; Francomano E; Scarlato G Riv Neurol; 1987; 57(1):13-9. PubMed ID: 3629125 [TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta. Lundkvist M; Greiner E; Hillert J; Fogdell-Hahn A Mult Scler; 2010 Jul; 16(7):796-800. PubMed ID: 20534645 [TBL] [Abstract][Full Text] [Related]
32. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Imrell K; Landtblom AM; Hillert J; Masterman T Neurology; 2006 Sep; 67(6):1062-4. PubMed ID: 17000979 [TBL] [Abstract][Full Text] [Related]
33. The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis. Axelsson M; Mattsson N; Malmeström C; Zetterberg H; Lycke J J Neuroimmunol; 2013 Nov; 264(1-2):100-5. PubMed ID: 24125567 [TBL] [Abstract][Full Text] [Related]
34. Intrathecal immunoglobulin G synthesis and brain injury by quantitative MRI in multiple sclerosis. Brandão CO; Ruocco HH; Farias AS; Oliveira C; Cendes F; Damasceno BP; Santos LM Neuroimmunomodulation; 2006; 13(2):89-95. PubMed ID: 17033198 [TBL] [Abstract][Full Text] [Related]
35. Lymphocyte subsets in multiple sclerosis. A study with two-colour fluorescence analysis. Bongioanni P; Fioretti C; Vanacore R; Bianchi F; Lombardo F; Ambrogi F; Meucci G J Neurol Sci; 1996 Jul; 139(1):71-7. PubMed ID: 8836975 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Harrer A; Tumani H; Niendorf S; Lauda F; Geis C; Weishaupt A; Kleinschnitz C; Rauer S; Kuhle J; Stangel M; Weber F; Uhr M; Linnebank M; Wildemann B; Jarius S; Guger M; Ayzenberg I; Chan A; Zettl U; Wiendl H; Pilz G; Hitzl W; Weber JR; Kraus J Mult Scler; 2013 Aug; 19(9):1209-12. PubMed ID: 23093485 [TBL] [Abstract][Full Text] [Related]
37. B cells undergo unique compartmentalized redistribution in multiple sclerosis. Haas J; Bekeredjian-Ding I; Milkova M; Balint B; Schwarz A; Korporal M; Jarius S; Fritz B; Lorenz HM; Wildemann B J Autoimmun; 2011 Dec; 37(4):289-99. PubMed ID: 21924866 [TBL] [Abstract][Full Text] [Related]
38. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution. Beseler C; Vollmer T; Graner M; Yu X PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249 [TBL] [Abstract][Full Text] [Related]
39. Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Thangarajh M; Gomez-Rial J; Hedström AK; Hillert J; Alvarez-Cermeño JC; Masterman T; Villar LM Mult Scler; 2008 Nov; 14(9):1208-13. PubMed ID: 18755821 [TBL] [Abstract][Full Text] [Related]
40. Immunological markers of optimal response to natalizumab in multiple sclerosis. Villar LM; García-Sánchez MI; Costa-Frossard L; Espiño M; Roldán E; Páramo D; Lucas M; Izquierdo G; Álvarez-Cermeño JC Arch Neurol; 2012 Feb; 69(2):191-7. PubMed ID: 22332187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]